Menthol, Inflammation, and Nicotine Transition Study

Launched by ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE · Jan 22, 2024

Keywords

ClinConnect Summary

The Menthol, Inflammation, and Nicotine Transition Study is looking into how menthol flavoring in cigarettes might affect inflammation in the body, which can be an early sign of heart disease risk. Researchers want to understand if using menthol cigarettes leads to different health effects compared to non-menthol cigarettes.

To participate in this study, you need to be between 21 and 85 years old, smoke menthol cigarettes at least five times a day for over a year, and have a smartphone to use a specific app. It's important to note that if you are pregnant, trying to quit smoking, or have certain health issues, you won't be eligible to join. If you qualify, you'll be contributing to important research that could help us learn more about the health risks associated with menthol smoking.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • Men and women between 21-85 years old
• • Currently uses menthol cigarettes
• • Daily smoking rate of ≥5 cigarettes/day for ≥1 year
• • Currently own and regularly use an iOS/Android smartphone device able to download the LifeData application
• • Able to read and communicate fluently in English
• • Exclusion criteria
• • Currently pregnant or breastfeeding
• • Actively trying to quit smoking
• • Current heavy alcohol use
• • Frequent use of non-menthol cigarettes, other smoking products, or illicit substances
• • History of severe medical/psychiatric condition or treatment